Abstract
Aim: Review of the present data from investigations on the role of statins in the treatment of PCOS. Materials and methods: Systematic approach of the available scientific literature on the problem. Results: Polycystic ovary syndrome (PCOS) is common endocrine disorder in women in reproductive age. It is associated with menstrual disorder and disturbance of reproductive and metabolic functions in severe form.Often the syndrome is connected with insulin resistance,systemic inflammation and oxidative stress which lead to endothelial dysfunction and dyslipidemia. Statins are inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase with intrinsic antioxidant properties. By blocking an early step of the mevalonate pathway, statins inhibit proliferation of several cell types, improve the lipid and hormone profile of women with PCOS. This article reviews the present data from investigations with statins and their role in PCOS. Conclusions: The recent investigations suggest that statins have potential in the treatment of PCOS.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.